SEC Form 4 · accession 0001219036-18-000004
MYRIAD GENETICS INC · MYGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jerry S Lanchbury
Officer — Chief Scientific Officer
Period of report
Jul 11, 2018
Accepted (ET)
Jul 13, 2018 · 4:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000899923
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 11, 2018 | M | 46,139 | $30.34 | A | 184,948 | D | |
| Common Stock | Jul 11, 2018 | S | 46,139 | $43.3408 | D | 138,809 | D | |
| Common Stock | Jul 11, 2018 | M | 3,861 | $30.34 | A | 142,670 | D | |
| Common Stock | Jul 11, 2018 | S | 3,861 | $43.3408 | D | 138,809 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy) | $30.34 | Jul 11, 2018 | M | 3,861 | D | Sep 15, 2013 | Sep 15, 2019 | Common Stock | 3,861 | 0 | D |
| Non-Qualified Stock Option (right to buy) | $30.34 | Jul 11, 2018 | M | 46,139 | D | Sep 15, 2013 | Sep 15, 2019 | Common Stock | 46,139 | 0 | D |
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan.